Acumen Hypotension Prediction Index (HPI) Feature Software vs Rapid RV/LV

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by RapidAI (formerly iSchemaView)

AI Verdict

Tool A specializes in real-time prediction and management of hypotension using physiological monitoring data for proactive hemodynamic management. In contrast, Tool B focuses on the rapid, AI-powered assessment of pulmonary embolism severity by analyzing CTPA imaging to measure ventricular ratios. While both are cardiology-focused AI tools, they address distinct clinical problems with different data inputs and workflows, making them complementary rather than directly competitive.

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…

Choose Acumen Hypotension Prediction Index (HPI) if your primary goal is proactive, real-time prevention of hypotensive events in critically ill or surgical patients. This tool is ideal for continuous hemodynamic monitoring, providing early alerts and actionable insights into underlying physiological parameters to guide timely interventions.

View Acumen Hypotension Prediction Index (HPI) Feature Software →

Choose Rapid RV/LV if…

Choose Rapid RV/LV if you require rapid, AI-driven assessment of pulmonary embolism severity directly from CTPA scans. This tool is best suited for emergency departments or critical care settings where quick, objective measurement of right and left ventricle ratios is crucial for guiding immediate treatment decisions and patient triage.

View Rapid RV/LV →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index (HPI) Feature Software Rapid RV/LV
Pricing Unknown Contact vendor for pricing information.
Deployment Unknown On-premises (dedicated server or virtual machine) or hybrid (on-premises/cloud with secure link to cloud), connecting to hospital LAN/firewall.
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rapid RV/LV

Rapid RV/LV (Tool B) offers a more comprehensive user experience by integrating into the broader RapidAI platform, which includes mobile alerts, in-app messaging, and EMR integration, streamlining care coordination for the entire team. While Acumen HPI (Tool A) provides real-time monitoring with a clear score and alerts, Tool B's ecosystem approach to workflow and communication provides a broader usability advantage.

Clinical Value

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI (Tool A) demonstrates stronger direct clinical value with documented evidence of reducing the incidence, duration, and severity of intraoperative hypotension. It proactively predicts hypotensive events up to 15 minutes in advance, enabling earlier intervention and improved patient outcomes. Rapid RV/LV (Tool B) improves diagnostic efficiency and consistency for pulmonary embolism, which is valuable, but its direct impact on patient outcomes is less explicitly detailed than Tool A's.

Pricing & Value

Rapid RV/LV

Rapid RV/LV (Tool B) provides slightly more pricing transparency, with an annual subscription model starting around $12,000 for a single module in the US, including support and training. It also highlights an 'immeasurable' return on investment through improved responsiveness and better transfer decisions. Acumen HPI (Tool A) only states 'contact vendor' for pricing, offering less insight into its commercial approach, and a 2021 report noted no evidence of cost savings at that time.

Enterprise Readiness

Rapid RV/LV

Rapid RV/LV (Tool B) offers greater enterprise readiness due to its flexible deployment options (on-premises or hybrid) and explicit integration capabilities with PACS and EMR systems, which are essential for seamless adoption within diverse hospital IT infrastructures. Both tools are FDA-cleared, HIPAA compliant, and have BAAs, but Acumen HPI (Tool A) is integrated into a specific proprietary monitoring platform, which may limit its flexibility for some enterprises.

Innovation

Acumen Hypotension Prediction Index (HPI) Feature Software

Acumen HPI (Tool A) is more innovative as it utilizes machine learning for real-time, continuous predictive analysis of physiological waveforms to anticipate a critical event (hypotension) up to 15 minutes before it occurs, a 'first-of-its-kind' approach in continuous patient monitoring. While Rapid RV/LV (Tool B) innovates by automating a specific, critical diagnostic measurement from imaging, Tool A's real-time predictive capability for an impending physiological change represents a higher degree of innovation in patient management.

Support & Docs

Rapid RV/LV

Rapid RV/LV (Tool B) offers more explicit and comprehensive support, including 24/7/365 availability via email and phone, with multilingual technical experts, which is crucial for enterprise-level healthcare solutions operating around the clock. While Acumen HPI (Tool A) mentions clinical education and customer service, it lacks the specific, round-the-clock, multi-channel support details provided by RapidAI.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index (HPI) Feature Software Rapid RV/LV
Name Acumen Hypotension Prediction Index (HPI) Feature Software Rapid RV/LV
Company Edwards Lifesciences RapidAI (formerly iSchemaView)
Primary Function Predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs. FDA-cleared AI tool for rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans.
Key AI Application Machine learning algorithms for predictive analysis of blood pressure waveforms. AI-powered analysis of CTPA images for automated measurement of right and left ventricle diameters.
Specific Output/Metric Hypotension Prediction Index (HPI) parameter (0-100 score), Smart Alerts and Smart Trend screen. Automated measurement of right and left ventricle diameters, calculation of RV/LV ratio, annotated images.
Input Data Type Invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring data. CTPA scans.
Predictive Capability Predicts hypotension up to 15 minutes before an event. Not specified

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index (HPI) Feature Software and Rapid RV/LV.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Acumen HPI is integrated into the Edwards Lifesciences HemoSphere advanced monitoring platform and is designed for real-time, continuous monitoring to predict and aid in treating hypotensive events in surgical and non-surgical patients receiving advanced hemodynamic monitoring. Rapid RV/LV by RapidAI is an AI tool for rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans, primarily benefiting cardiology, pulmonology, and radiology workflows for triage and notification.
Acumen HPI is integrated into the Edwards Lifesciences HemoSphere advanced monitoring platform, which implies data flow within that monitoring ecosystem. Rapid RV/LV connects to the hospital LAN/firewall and integrates with the broader Rapid PE solution, and can integrate with PACS and EHR systems, facilitating the transfer of analysis results and notifications.
Acumen HPI predicts hypotension up to 15 minutes before an event and has demonstrated a reduction in the incidence, duration, and severity of intraoperative hypotension. Rapid RV/LV provides automated measurements of right and left ventricle diameters and RV/LV ratios from CTPA images, delivering rapid results within minutes and reducing inter-rater variability in PE severity assessment.
For Acumen HPI, clinicians would need to learn to interpret the HPI parameter (0-100 score), Smart Alerts, Smart Trend screen, and the Relationship View providing insights into preload, afterload, and contractility. For Rapid RV/LV, the learning curve would involve understanding the automated RV/LV ratio calculation and interpreting the annotated images showing ventricular measurements.
The provided information does not explicitly detail specific audit-trail features for Acumen Hypotension Prediction Index (HPI) Feature Software. RapidAI states that its platform includes real-time monitoring and logging with built-in telemetry, comprehensive incident management, and user access and management controls, which contribute to auditability.
For Acumen HPI, multi-site rollout would likely involve ensuring consistent deployment of the Edwards Lifesciences HemoSphere advanced monitoring platform across all sites. Rapid RV/LV offers deployment options including on-premises or hybrid models, requiring considerations for dedicated servers or virtual machines and secure connections to each hospital's LAN/firewall.
AI Tool Finder
AI-powered search. Results may not be comprehensive.